ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+12.61%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$935M
AUM Growth
+$935M
(+8.4%)
Cap. Flow
+$12.7M
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
41.74%
Holding
114
New
20
Increased
25
Reduced
19
Closed
21
Top Buys
| 1 |
TLN
Talen Energy Corporation Common Stock
TLN
|
$15.9M |
| 2 |
Amazon
AMZN
|
$13.4M |
| 3 |
GE Vernova
GEV
|
$11M |
| 4 |
Enphase Energy
ENPH
|
$10.7M |
| 5 |
CAVA Group
CAVA
|
$10.5M |
Top Sells
| 1 |
Apple
AAPL
|
$12.6M |
| 2 |
Merck
MRK
|
$10.3M |
| 3 |
Arm
ARM
|
$9.87M |
| 4 |
HubSpot
HUBS
|
$9.73M |
| 5 |
Novo Nordisk
NVO
|
$9.71M |
Sector Composition
| 1 | Healthcare | 28.83% |
| 2 | Technology | 26.63% |
| 3 | Consumer Discretionary | 15.29% |
| 4 | Industrials | 12.17% |
| 5 | Communication Services | 4.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Exact Sciences
EXAS
$8.98B
| – | – |
-211,120
| Closed | -$8.92M |
|
77
Freeport-McMoran
FCX
$63.7B
| – | – |
-175,500
| Closed | -$8.53M |
|
78
FIVE9
FIVN
$2.08B
| – | – |
0
| – | – |
|
79
GitLab
GTLB
$7.93B
| – | – |
-78,000
| Closed | -$3.88M |
|
|
80
HubSpot
HUBS
$25.5B
| – | – |
-16,500
| Closed | -$9.73M |
|
81
Immunome
IMNM
$828M
| – | – |
-74,000
| Closed | -$895K |
|
82
InMode
INMD
$944M
| – | – |
0
| – | – |
|
83
Cassava Sciences
SAVA
$110M
| – | – |
0
| – | – |
|
|
84
Apple
AAPL
$3.45T
| – | – |
-60,000
| Closed | -$12.6M |
|
85
ASML
ASML
$292B
| – | – |
-5,700
| Closed | -$5.83M |
|
86
AtriCure
ATRC
$1.84B
| – | – |
0
| – | – |
|
87
BridgeBio Pharma
BBIO
$9.89B
| – | – |
0
| – | – |
|
88
Boston Scientific
BSX
$156B
| – | – |
-101,000
| Closed | -$7.78M |
|
89
Cabaletta Bio
CABA
$133M
| – | – |
0
| – | – |
|
90
Coherent
COHR
$14.1B
| – | – |
-21,000
| Closed | -$1.52M |
|
91
Datadog
DDOG
$47.7B
| – | – |
-74,000
| Closed | -$9.6M |
|
92
Dyne Therapeutics
DYN
$1.92B
| – | – |
-181,500
| Closed | -$6.41M |
|
93
Elanco Animal Health
ELAN
$9.12B
| – | – |
-203,985
| Closed | -$2.94M |
|
94
Levi Strauss
LEVI
$8.85B
| – | – |
0
| – | – |
|
95
Lumen
LUMN
$5.1B
| – | – |
0
| – | – |
|
96
monday.com
MNDY
$9.95B
| – | – |
-17,000
| Closed | -$4.09M |
|
|
97
Merck
MRK
$210B
| – | – |
-83,000
| Closed | -$10.3M |
|
98
Moderna
MRNA
$9.37B
| – | – |
0
| – | – |
|
99
Neurocrine Biosciences
NBIX
$13.8B
| – | – |
-44,500
| Closed | -$6.13M |
|
|
100
Novo Nordisk
NVO
$251B
| – | – |
-68,000
| Closed | -$9.71M |
|